PPD：2023年全球医药研发动向报告：150位行业领导者洞见（英文版）（44页）.pdf

1、THE WORLD LEADER IN SERVING SCIENCE1Copyright 2023 by Pharmaceutical Product Development(“PPD”),part of Thermo Fisher Scientific.All rights reserved.THE PULSE 2023Global R&D Insights in Pharmaceuticals Methodology&Profile 3Executive Summary 8Industry Trends&Challenges 16Hot Topics 24Outsourcing 28Ap

2、pendix 32THE WORLD LEADER IN SERVING SCIENCE2Copyright 2023 by Pharmaceutical Product Development(“PPD”),part of Thermo Fisher Scientific.All rights reserved.About The PulseThe future for drug developers is defined by how effectively they adopt innovative strategies and new technologies,while naviga

3、ting industry challenges and complexities.Thats why the PPD clinical research business of Thermo Fisher Scientific surveyed 150 leaders at biotech and pharmaceutical organizations around the globe to assess trends in drug discovery and development.Respondents shared the therapeutic areas in their pi

4、pelines,barriers to bringing drugs to market,innovations that are driving transformation,and attitudes toward key topics such as outsourcing,patient recruitment,diversity,decentralized trials,and more.In our second annual report,youll go beyond the data to learn what these insights mean for drug dev

5、elopers across the globe,and how you can prepare to successfully navigate the evolving drug development landscape.Discover what industry leaders are facing today,and how their outlook on pharmaceutical research and development is pushing the industry forward.Copyright 2023 by Pharmaceutical Product

6、Development(“PPD”),part of Thermo Fisher Scientific.All rights reserved.This report,including the information contained herein and commentary associated herewith(“materials”),is provided as a service of PPD.TheseMaterials,basedon publicly available information,market research conducted on behalf of